Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECLIPSE: Flotufolastat F 18 PET/CT Following Prostate Focal Therapy
NCT07185165Phase 2Recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Oct 2025
- Primary completion
- Oct 2035
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flotufolastat f 18 in prostate cancer (PCa), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Oct 2025; status: recruiting.
02
Drugs
flotufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07185165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185165.